Earnings Call · Q2 FY2024·2024-08-06

Q2 24EPS +7.14%·Rev n/aQ1 24EPS +12.50%·Rev n/aQ4 23EPS -33.33%·Rev n/aQ3 23EPS +23.08%·Rev n/a⚠ consensus missing

AbCellera Biologics Inc. ABCL

Tryn Stimart — Chief Legal and Compliance Officer

Dr. Carl Hansen — Chief Executive Officer

Andrew Booth — Chief Financial Officer

+3.3%1d on move date+2.3% vs SPY3d+0.4%5d−4.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABCL calls or request research access.

More ABCL calls Browse calls Request research access